247 related articles for article (PubMed ID: 33820855)
1. STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways.
Johnson BM; Uchimura T; Gallovic MD; Thamilarasan M; Chou WC; Gibson SA; Deng M; Tam JW; Batty CJ; Williams J; Matsushima GK; Bachelder EM; Ainslie KM; Markovic-Plese S; Ting JP
J Immunol; 2021 May; 206(9):2015-2028. PubMed ID: 33820855
[TBL] [Abstract][Full Text] [Related]
2. A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination.
Junkins RD; Gallovic MD; Johnson BM; Collier MA; Watkins-Schulz R; Cheng N; David CN; McGee CE; Sempowski GD; Shterev I; McKinnon K; Bachelder EM; Ainslie KM; Ting JP
J Control Release; 2018 Jan; 270():1-13. PubMed ID: 29170142
[TBL] [Abstract][Full Text] [Related]
3. cGAS exacerbates Schistosoma japonicum infection in a STING-type I IFN-dependent and independent manner.
Liang L; Shen Y; Hu Y; Liu H; Cao J
PLoS Pathog; 2022 Feb; 18(2):e1010233. PubMed ID: 35108342
[TBL] [Abstract][Full Text] [Related]
4. The STING-IFN-β-Dependent Axis Is Markedly Low in Patients with Relapsing-Remitting Multiple Sclerosis.
Masanneck L; Eichler S; Vogelsang A; Korsen M; Wiendl H; Budde T; Meuth SG
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291536
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response.
Marcus A; Mao AJ; Lensink-Vasan M; Wang L; Vance RE; Raulet DH
Immunity; 2018 Oct; 49(4):754-763.e4. PubMed ID: 30332631
[TBL] [Abstract][Full Text] [Related]
6. Transfer of cGAMP into Bystander Cells via LRRC8 Volume-Regulated Anion Channels Augments STING-Mediated Interferon Responses and Anti-viral Immunity.
Zhou C; Chen X; Planells-Cases R; Chu J; Wang L; Cao L; Li Z; López-Cayuqueo KI; Xie Y; Ye S; Wang X; Ullrich F; Ma S; Fang Y; Zhang X; Qian Z; Liang X; Cai SQ; Jiang Z; Zhou D; Leng Q; Xiao TS; Lan K; Yang J; Li H; Peng C; Qiu Z; Jentsch TJ; Xiao H
Immunity; 2020 May; 52(5):767-781.e6. PubMed ID: 32277911
[TBL] [Abstract][Full Text] [Related]
7. Cytosolic d-type CpG-oligonucleotides induce a type I interferon response by activating the cGAS-STING signaling pathway.
Bode C; Poth JM; Fox M; Schulz S; Klinman DM; Latz E; Steinhagen F
Eur J Immunol; 2021 Jul; 51(7):1686-1697. PubMed ID: 33860535
[TBL] [Abstract][Full Text] [Related]
8. Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists.
Collier MA; Junkins RD; Gallovic MD; Johnson BM; Johnson MM; Macintyre AN; Sempowski GD; Bachelder EM; Ting JP; Ainslie KM
Mol Pharm; 2018 Nov; 15(11):4933-4946. PubMed ID: 30281314
[TBL] [Abstract][Full Text] [Related]
9. TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
Temizoz B; Kuroda E; Ohata K; Jounai N; Ozasa K; Kobiyama K; Aoshi T; Ishii KJ
Eur J Immunol; 2015 Apr; 45(4):1159-69. PubMed ID: 25529558
[TBL] [Abstract][Full Text] [Related]
10. STING agonists enable antiviral cross-talk between human cells and confer protection against genital herpes in mice.
Skouboe MK; Knudsen A; Reinert LS; Boularan C; Lioux T; Perouzel E; Thomsen MK; Paludan SR
PLoS Pathog; 2018 Apr; 14(4):e1006976. PubMed ID: 29608601
[TBL] [Abstract][Full Text] [Related]
11. A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatment.
Nagata M; Kosaka A; Yajima Y; Yasuda S; Ohara M; Ohara K; Harabuchi S; Hayashi R; Funakoshi H; Ueda J; Kumai T; Nagato T; Oikawa K; Harabuchi Y; Esteban C; Ohkuri T; Kobayashi H
Cancer Immunol Immunother; 2021 Aug; 70(8):2301-2312. PubMed ID: 33507344
[TBL] [Abstract][Full Text] [Related]
12. Activation of the STING adaptor attenuates experimental autoimmune encephalitis.
Lemos H; Huang L; Chandler PR; Mohamed E; Souza GR; Li L; Pacholczyk G; Barber GN; Hayakawa Y; Munn DH; Mellor AL
J Immunol; 2014 Jun; 192(12):5571-8. PubMed ID: 24799564
[TBL] [Abstract][Full Text] [Related]
13. The role of cGAMP via the STING pathway in modulating germinal center responses and CD4 T cell differentiation.
Yoon M; Choi Y; Wi T; Choi YS; Choi J
Front Immunol; 2024; 15():1340001. PubMed ID: 38680492
[TBL] [Abstract][Full Text] [Related]
14. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.
Rueckert C; Rand U; Roy U; Kasmapour B; Strowig T; Guzmán CA
FASEB J; 2017 Jul; 31(7):3107-3115. PubMed ID: 28396343
[TBL] [Abstract][Full Text] [Related]
15. Microparticle Delivery of a STING Agonist Enables Indirect Activation of NK Cells by Antigen-Presenting Cells.
Watkins-Schulz R; Batty CJ; Stiepel RT; Schmidt ME; Sandor AM; Chou WC; Ainslie KM; Bachelder EM; Ting JP
Mol Pharm; 2022 Sep; 19(9):3125-3138. PubMed ID: 35913984
[TBL] [Abstract][Full Text] [Related]
16. Activation of STING signaling accelerates skin wound healing.
Mizutani Y; Kanbe A; Ito H; Seishima M
J Dermatol Sci; 2020 Jan; 97(1):21-29. PubMed ID: 31813660
[TBL] [Abstract][Full Text] [Related]
17. Triggering of the cGAS-STING Pathway in Human Plasmacytoid Dendritic Cells Inhibits TLR9-Mediated IFN Production.
Deb P; Dai J; Singh S; Kalyoussef E; Fitzgerald-Bocarsly P
J Immunol; 2020 Jul; 205(1):223-236. PubMed ID: 32471881
[TBL] [Abstract][Full Text] [Related]
18. Cyclic GMP-AMP Triggers Asthma in an IL-33-Dependent Manner That Is Blocked by Amlexanox, a TBK1 Inhibitor.
Ozasa K; Temizoz B; Kusakabe T; Kobari S; Momota M; Coban C; Ito S; Kobiyama K; Kuroda E; Ishii KJ
Front Immunol; 2019; 10():2212. PubMed ID: 31616416
[TBL] [Abstract][Full Text] [Related]
19. Sublingual targeting of STING with 3'3'-cGAMP promotes systemic and mucosal immunity against anthrax toxins.
Martin TL; Jee J; Kim E; Steiner HE; Cormet-Boyaka E; Boyaka PN
Vaccine; 2017 Apr; 35(18):2511-2519. PubMed ID: 28343781
[TBL] [Abstract][Full Text] [Related]
20. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
